Tag: life sciences
-

Biotechs to Develop Personal Cancer-Killing Virus Vaccines
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system.
-

RNA Therapeutics Company Raises $30M in First Venture Round
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells.
-

NIH Funds Support for Point-of-Care Device Entrepreneurs
Two institutions in Massachusetts are starting a program to help inventors and new enterprises anywhere in the U.S. bring their point-of-care medical devices to market.
-

Phone App Shown to Detect Serious Heart Attack
A smartphone app that monitors heart functions like an electrocardiogram, or EKG, can detect a dangerous form of heart attack, according to results of a clinical trial.
-

Infographic – Superbugs Annually Kill 33,000 in Europe
Our friends at Statista posted a chart showing the median number of deaths by country in Europe from microbes resistant to antibiotics, this weekend’s infographic.
-

$200M Gift Supporting Translational Research, Start-Up Incubator
Harvard Medical School is the recipient of a gift from the Blavatnik Family Foundation to develop innovative treatments, apply advanced digital technologies, and accelerate biotech and life science start-up companies.
-

Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own.
-

Modified Cancer Drug Hastens Bone Fracture Healing
A current drug for leukemia, with a simple protein chemically added, is shown in tests with lab mice to accelerate the healing of broken bones.
-

Nanotech Immunotherapy Reduces Heart Transplant Rejection
Proteins known to regulate immune cells, given as nanoscale particles, are shown in lab mice to encourage long-term acceptance of a transplanted heart.
-

NIH Award Supports Esophagus Tissue Implants from Stem Cells
A company developing engineered tissue implants from stem cells received a grant from National Institutes of Health to develop an implant to correct a congenital defect in a newborn infant’s esophagus.